sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
INBX
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | Buy | $998,784 | Lappe Mark Chief Executive Officer, Director | 10,000 sh | at $99.88 | Filed Sep 28, 5:47 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Buy | $500,000 | Kayyem Jon Faiz Director | 5,000 sh | at $100.00 | Filed Sep 23, 4:59 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Buy | $500,000 | Kayyem Jon Faiz Director | 5,000 sh | at $100.00 | Filed Sep 17, 5:46 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Sale | $163,543 | MANHARD KIMBERLY Director | 1,500 sh | at $109.03 | Filed Sep 15, 5:52 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Sale | $115,468 | MANHARD KIMBERLY Director | 1,000 sh | at $115.47 | Filed Sep 10, 7:06 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Buy | $567,580 | Kayyem Jon Faiz Director | 5,000 sh | at $113.52 | Filed Sep 8, 5:23 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Buy | $286,617 | FORSYTH DOUGLAS Director | 2,500 sh | at $114.65 | Filed Sep 8, 4:26 PM ET | Filing | |
| INBX Inhibrx Biosciences, Inc. | Buy | $2,645,399 | Lappe Mark Chief Executive Officer, Director | 25,000 sh | at $105.82 | Filed Sep 8, 4:04 PM ET | Filing |